These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10393567)

  • 21. Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation.
    Kartal A; Björkqvist M; Lehto VP; Juppo AM; Marvola M; Sivén M
    J Pharm Pharmacol; 2008 Sep; 60(9):1131-8. PubMed ID: 18718115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermodynamics of water-solid interactions in crystalline and amorphous pharmaceutical materials.
    Sacchetti M
    J Pharm Sci; 2014 Sep; 103(9):2772-2783. PubMed ID: 24327540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
    Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preformulation considerations for controlled release dosage forms. Part II. Selected candidate support.
    Chrzanowski F
    AAPS PharmSciTech; 2008; 9(2):639-45. PubMed ID: 18431656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amlodipine besylate-excipients interaction in solid dosage form.
    Abdoh A; Al-Omari MM; Badwan AA; Jaber AM
    Pharm Dev Technol; 2004; 9(1):15-24. PubMed ID: 15000463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The solution, solid state stability and kinetic investigation in degradation studies of lercanidipine: study of excipients compatibility of lercanidipine.
    Parmar N; Amin S; Singla N; Kohli K
    Pharm Dev Technol; 2012; 17(6):730-40. PubMed ID: 21599490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-Excipient Interactions in the Solid State: The Role of Different Stress Factors.
    Gressl C; Brunsteiner M; Davis A; Landis M; Pencheva K; Scrivens G; Sluggett GW; Wood GPF; Gruber-Woelfler H; Khinast JG; Paudel A
    Mol Pharm; 2017 Dec; 14(12):4560-4571. PubMed ID: 29058913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slow dissolution behaviour of amorphous capecitabine.
    Meulenaar J; Beijnen JH; Schellens JH; Nuijen B
    Int J Pharm; 2013 Jan; 441(1-2):213-7. PubMed ID: 23219704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The solid-state continuum: a perspective on the interrelationships between different solid-state forms in drug substance and drug product.
    Elder DP; Patterson JE; Holm R
    J Pharm Pharmacol; 2015 Jun; 67(6):757-72. PubMed ID: 25124049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new approach to accelerated drug-excipient compatibility testing.
    Sims JL; Carreira JA; Carrier DJ; Crabtree SR; Easton L; Hancock SA; Simcox CE
    Pharm Dev Technol; 2003; 8(2):119-26. PubMed ID: 12760562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A high throughput platform for understanding the influence of excipients on physical and chemical stability.
    Raijada D; Cornett C; Rantanen J
    Int J Pharm; 2013 Aug; 453(1):285-92. PubMed ID: 22944300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermal analysis study of the interactions between acetaminophen and excipients in solid dosage forms and in some binary mixtures.
    Tomassetti M; Catalani A; Rossi V; Vecchio S
    J Pharm Biomed Anal; 2005 Apr; 37(5):949-55. PubMed ID: 15862672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in crystallization rate of nitrendipine enantiomers in amorphous solid dispersions with HPMC and HPMCP.
    Miyazaki T; Aso Y; Yoshioka S; Kawanishi T
    Int J Pharm; 2011 Apr; 407(1-2):111-8. PubMed ID: 21277962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Eur J Pharm Sci; 2008 Mar; 33(3):294-305. PubMed ID: 18262776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Rapid 3-Day Excipient Screening Methodology and its Application in Identifying Chemical Stabilizers for Solid Formulations with Mixed Mechanisms of Degradation.
    Matharu AS; Dhareshwar SS; Cao YJ
    AAPS PharmSciTech; 2024 Jan; 25(1):12. PubMed ID: 38182862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excipient hydrolysis and ester formation increase pH in a parenteral solution over aging.
    Hirakura Y; Nakamura M; Wakasawa T; Ban K; Yokota S; Kitamura S
    Int J Pharm; 2006 Nov; 325(1-2):26-38. PubMed ID: 16860951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
    Amharar Y; Curtin V; Gallagher KH; Healy AM
    Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid state stability of ketoprofen in the presence of different excipients.
    Abd-el-Bary A; Geneidy A; Osman A; Shalaby S; Morshan A
    Pharmazie; 1999 Mar; 54(3):202-6. PubMed ID: 10192106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of photostability and compatibility of the anti-chagas drug Benznidazole with pharmaceutics excipients.
    Santos FL; Rolim LA; Figueirêdo CB; Lyra MA; Peixoto MS; Ferraz LR; Soares-Sobrinho JL; Neves de Lima ÁA; Lima Leite AC; Rolim Neto PJ
    Drug Dev Ind Pharm; 2015 Jan; 41(1):63-9. PubMed ID: 24134564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational excipient selection for co-amorphous formulations.
    Korhonen O; Pajula K; Laitinen R
    Expert Opin Drug Deliv; 2017 Apr; 14(4):551-569. PubMed ID: 27267873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.